These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 5950089)

  • 21. [Pathogenesis of ABO hemolytic disease of the newborn. Critical study].
    Lewi S
    Transfusion (Paris); 1966; 9(3):265-80. PubMed ID: 5969561
    [No Abstract]   [Full Text] [Related]  

  • 22. [Hemolytic diseases of the newborn caused by ABO incompatibility].
    TIMMERMAN J
    Belg Tijdschr Geneesk; 1963 Mar; 19():257-61. PubMed ID: 13985079
    [No Abstract]   [Full Text] [Related]  

  • 23. [Current state of ABO hemolytic disease of the newborn].
    Moretti M; Baroni M
    Pathologica; 1972; 64(935):303-8. PubMed ID: 4671450
    [No Abstract]   [Full Text] [Related]  

  • 24. Rh hemolytic disease of the newborn: its cause and prevention.
    Pollack W
    Prog Clin Biol Res; 1981; 70():185-302. PubMed ID: 6273932
    [No Abstract]   [Full Text] [Related]  

  • 25. [On the value of erythroblastosis and reticulosis in the post-natal diagnosis of ABO hemolytic disease].
    Gilardi G; Zara C
    Quad Clin Ostet Ginecol; 1968 Sep; 23(9):855-66. PubMed ID: 5754688
    [No Abstract]   [Full Text] [Related]  

  • 26. [Difficulties in the serological diagnosis of ABO erythroblastosis].
    Reichert K; Sachs V
    Zentralbl Gynakol; 1966 Oct; 88(40):1345-8. PubMed ID: 5995415
    [No Abstract]   [Full Text] [Related]  

  • 27. [Value of thermo-resistant immune antibodies active against cord erythrocytes for the diagnosis of hemolytic disease of the newborn caused by ABO incompatibility].
    Ottaviano S; Menghetti E; Mencarini L; Carapella de Luca E
    Riv Ostet Ginecol; 1969 May; 24(5):163-70. PubMed ID: 5393391
    [No Abstract]   [Full Text] [Related]  

  • 28. [ABO hemolytic disease of the newborn. Criteria for prognostic and therapeutic evaluation (except exsanguination transfusion)].
    Salvioli GP
    Pathologica; 1972; 64(935):309-14. PubMed ID: 4671451
    [No Abstract]   [Full Text] [Related]  

  • 29. ABO hemolytic disease of the newborn as a selection mechanism at the ABO locus.
    Sever LE
    Am J Phys Anthropol; 1969 Sep; 31(2):177-86. PubMed ID: 5388668
    [No Abstract]   [Full Text] [Related]  

  • 30. [Studies of the pathogenesis of the ABO incompatibility of newborn infants. (The influence of the child's secretor properties on the antibody titer of the mother)].
    Schneeweiss B; Wernitz C
    Zentralbl Gynakol; 1967 Sep; 89(35):1269-75. PubMed ID: 5598275
    [No Abstract]   [Full Text] [Related]  

  • 31. ABO hemolytic disease, complement, and phagocytosis.
    Gordon BD; Desforges J
    Pediatrics; 1972 Jul; 50(1):169. PubMed ID: 5038101
    [No Abstract]   [Full Text] [Related]  

  • 32. [Hemolytic disease caused by ABO factors. Statistical and therapeutic considerations on a 2-year period].
    Vignolo Lutati U; Gavinelli R
    Minerva Pediatr; 1971 Aug; 23(33):1383-7. PubMed ID: 5166215
    [No Abstract]   [Full Text] [Related]  

  • 33. SEROLOGICAL ASPECT OF HEMOLYTIC DISEASE OF NEWBORN.
    ISLAMI ZS
    Va Med Mon (1918); 1963 Oct; 90():530. PubMed ID: 14069389
    [No Abstract]   [Full Text] [Related]  

  • 34. ABO hemolytic disease of the newborn associated with direct reacting hyperbilirubinemia.
    Najak Z; Kanto WP; Carrillo PJ
    J Med Assoc Ga; 1982 Apr; 71(4):267-71. PubMed ID: 7200505
    [No Abstract]   [Full Text] [Related]  

  • 35. [Laboratory study of traditional Chinese medicine for the prevention and treatment of hemolytic diseases of the newborn infant].
    Qian ML
    Zhonghua Fu Chan Ke Za Zhi; 1984 Oct; 19(4):207-9, 256. PubMed ID: 6543580
    [No Abstract]   [Full Text] [Related]  

  • 36. [Hemolytic disease of the newborn as a result of ABO incompatibility and unusual fetogenic sensitizations].
    DAMEROW R
    Ergeb Inn Med Kinderheilkd; 1963; 19():132-205. PubMed ID: 14024821
    [No Abstract]   [Full Text] [Related]  

  • 37. Fetomaternal blood group incompatibility studies in placental intervillous thrombosis.
    Batcup G; Tovey LA; Longster G
    Placenta; 1983; 4 Spec No():449-53. PubMed ID: 6672809
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [ABO and Rh(D) blood groups in populations of the Lagunera region of Mexico (calculation of the incidence of single and double incompatibility between spouses and maternofetal incompatibility)].
    Garza Chapa R; Tobías Chávez R; Cerda Flores RM; Leal Garza CH
    Salud Publica Mex; 1984; 26(2):130-7. PubMed ID: 6427942
    [No Abstract]   [Full Text] [Related]  

  • 39. [Anemia in hemolytic disease of the newborn].
    Chashechkina IV
    Vopr Okhr Materin Det; 1972 Jun; 17(6):87. PubMed ID: 4672156
    [No Abstract]   [Full Text] [Related]  

  • 40. Recurrence rate of ABO hemolytic disease of the newborn.
    Katz MA; Kanto WP; Korotkin JH
    Obstet Gynecol; 1982 May; 59(5):611-4. PubMed ID: 7070734
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.